Clinical trial

Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps

NCT07046117

Study summary

ClinicalTrials.gov

Effect of Tezepelumab on Barrier Function in Severe Asthmatic Patients With and Without Comorbid Chronic Rhinosinusitis With Nasal Polyps

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Tezepelumab Normalized identity: tezepelumab View linked drug · Find medicine records · Find other trials using this name

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-10-01

PhaseNA

Conditions

Asthma Bronchialeunresolved

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)unresolved

Interventions

TezepelumabDRUG · verified · RxNorm: tezepelumab

Sponsors & collaborators

Medical University of Viennalead sponsor

Mapped research locations

ViennaAustria, Austria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07046117 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.